Particle.news

Download on the App Store

SNCF Reimburses Chemotherapy Patient Fined for Late Ticket Purchase

The operator reversed its stance after media reports highlighted the case of a 39-year-old undergoing chemotherapy who paid her fare on board.

Image
Image

Overview

  • Ludivine, a 39-year-old breast cancer patient travelling from Compiègne to Paris for a 9:30 a.m. chemotherapy session, bought an €8.50 ticket on board after her scheduled train was delayed and was fined €50 for late purchase.
  • She lodged an appeal with SNCF, providing her hospital appointment confirmation, and shared her experience on social media, attracting widespread messages of support.
  • SNCF policy mandates that passengers hold a valid ticket before departure and requires on-board purchasers to seek out conductors to avoid penalties.
  • Reports that conductors earn commissions of 4–10% on spot fines intensified criticism of rigid enforcement against a vulnerable traveller.
  • In response to public backlash and press coverage, SNCF agreed to reimburse Ludivine’s €50 fine, signaling a shift in applying its ticket-validation rules.